Hairy Cell Leukemia — Trials

Hairy Cell Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (20)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04815356	Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant	recruiting	Phase 1	27	National Cancer Institute (NCI)NIH	1	Sep 16, 2026	clinicaltrials
NCT06340737	AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas	recruiting	Phase 1	148	Stanford UniversityOTHER	1	Aug 12, 2026	clinicaltrials